Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver and Chitosan Nanoparticles in Endodontics
NCT06172023Completed
- Sponsor
- Minia University
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, open-label trial of silver nanoparticles in endodontic disease (3 arms), sponsored by Minia University. Primary endpoint: Postoperative Pain Assessment at 72 hours. Started Jan 2020; status: completed.
02
Drugs
silver nanoparticles
03
Conditions
endodontic disease
Beyond the preview
Go deeper on NCT06172023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06172023.